|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
DE3853515T3
(de)
|
1987-05-21 |
2005-08-25 |
Micromet Ag |
Multifunktionelle proteine mit vorbestimmter zielsetzung.
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
|
US6322789B1
(en)
|
1991-08-26 |
2001-11-27 |
Epimmune, Inc. |
HLA-restricted hepatitis B virus CTL epitopes
|
|
JP3540315B2
(ja)
|
1991-09-23 |
2004-07-07 |
メディカル リサーチ カウンシル |
キメラ抗体の製造−組合せアプローチ
|
|
AU3178993A
(en)
|
1991-11-25 |
1993-06-28 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
DE614989T1
(de)
|
1993-02-17 |
1995-09-28 |
Morphosys Proteinoptimierung |
Verfahren für in vivo Selektion von Ligandenbindende Proteine.
|
|
US5635363A
(en)
|
1995-02-28 |
1997-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
|
|
US5869270A
(en)
|
1996-01-31 |
1999-02-09 |
Sunol Molecular Corporation |
Single chain MHC complexes and uses thereof
|
|
US6211342B1
(en)
|
1996-07-18 |
2001-04-03 |
Children's Hospital Medical Center |
Multivalent MHC complex peptide fusion protein complex for stimulating specific T cell function
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
US6218363B1
(en)
|
1996-08-28 |
2001-04-17 |
Thomas Jefferson University |
MHC peptides and methods of use
|
|
JP3816959B2
(ja)
|
1997-02-13 |
2006-08-30 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
肝細胞癌の予防および処置
|
|
US7098306B2
(en)
|
1997-02-13 |
2006-08-29 |
The Regents Of The University Of California |
Method and compositions for treating hepatocellular cancer
|
|
US6268411B1
(en)
|
1997-09-11 |
2001-07-31 |
The Johns Hopkins University |
Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses
|
|
WO1998050527A1
(en)
|
1997-05-08 |
1998-11-12 |
Biomira Inc. |
Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
|
|
US20030007978A1
(en)
|
1997-09-16 |
2003-01-09 |
Burrows Gregory G. |
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
|
|
US6696304B1
(en)
|
1999-02-24 |
2004-02-24 |
Luminex Corporation |
Particulate solid phase immobilized protein quantitation
|
|
US7446189B1
(en)
|
1999-04-30 |
2008-11-04 |
Institut De Recherches Cliniques De Montreal |
Nucleic acids encoding mutant human CD80 and compositions comprising the same
|
|
US20020006664A1
(en)
|
1999-09-17 |
2002-01-17 |
Sabatini David M. |
Arrayed transfection method and uses related thereto
|
|
US6287860B1
(en)
|
2000-01-20 |
2001-09-11 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of MEKK2 expression
|
|
WO2001090747A2
(en)
|
2000-05-25 |
2001-11-29 |
Sunol Molecular Corporation |
Modulation of t-cell receptor interactions
|
|
US20020122820A1
(en)
|
2001-01-16 |
2002-09-05 |
Hildebrand William H. |
Soluble MHC artificial antigen presenting cells
|
|
US6800748B2
(en)
|
2001-01-25 |
2004-10-05 |
Large Scale Biology Corporation |
Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
|
|
CA2440773A1
(en)
|
2001-03-14 |
2002-09-19 |
Dakocytomation Denmark A/S |
Novel mhc molecule constructs, and methods of employing these constructs for diagnosis and therapy, and uses of mhc molecules
|
|
AU2002309865A1
(en)
|
2001-05-15 |
2002-11-25 |
University Of Medicine & Dentistry Of New Jersey |
Methods for analyzing interactions between proteins in live and intact cells
|
|
CN1533432A
(zh)
|
2001-06-04 |
2004-09-29 |
MLʵ���ҹ�������˾ |
高水平、大规模生产重组蛋白的组合体和方法
|
|
US20030017134A1
(en)
|
2001-06-19 |
2003-01-23 |
Technion Research And Development Foundation Ltd. |
Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
|
|
AU2002368044A1
(en)
|
2001-06-22 |
2004-04-19 |
Maxygen, Inc. |
Co-stimulatory molecules
|
|
WO2003006632A2
(en)
|
2001-07-12 |
2003-01-23 |
Canvac |
Methods and compisitions for activation human t cells in vitro
|
|
WO2003040307A2
(en)
|
2001-07-27 |
2003-05-15 |
Human Genome Sciences, Inc. |
Heteromultimeric tnf ligand family members
|
|
PT1454138E
(pt)
|
2001-12-04 |
2012-03-28 |
Merck Patent Gmbh |
Imunocitoquinas com seletividade modulada
|
|
CN100343393C
(zh)
|
2002-03-15 |
2007-10-17 |
布赖汉姆妇女医院 |
适合治疗剂全身性递送的中央气道给药
|
|
US8895020B2
(en)
|
2002-04-19 |
2014-11-25 |
Washington University |
Single chain trimers and uses therefor
|
|
US7611700B2
(en)
|
2002-09-09 |
2009-11-03 |
Hanall Pharmaceuticals, Co., Ltd. |
Protease resistant modified interferon alpha polypeptides
|
|
US7432351B1
(en)
|
2002-10-04 |
2008-10-07 |
Mayo Foundation For Medical Education And Research |
B7-H1 variants
|
|
US20070148162A1
(en)
|
2003-02-27 |
2007-06-28 |
Ranjit Bhardwaj |
Molecule which binds cd80 and cd86
|
|
AU2003901876A0
(en)
|
2003-04-17 |
2003-05-08 |
The Macfarlane Burnet Institute For Medical Research And Public Health |
Viral vector
|
|
US20050042641A1
(en)
|
2003-05-27 |
2005-02-24 |
Cold Spring Harbor Laboratory |
In vivo high throughput selection of RNAi probes
|
|
US7696306B2
(en)
|
2003-07-11 |
2010-04-13 |
Board of Agents of the University of Nebraska |
Compositions and methods for preventing or treating cancer
|
|
EP2783699A1
(en)
|
2003-09-05 |
2014-10-01 |
Oregon Health & Science University |
Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells
|
|
US7470513B2
(en)
|
2003-11-10 |
2008-12-30 |
Academia Sinica |
Risk assessment for adverse drug reactions
|
|
AU2005227263A1
(en)
|
2004-03-05 |
2005-10-06 |
Novartis Vaccines And Diagnostics, Inc. |
In vitro test system for predicting patient tolerability of therapeutic agents
|
|
DE102004014983A1
(de)
|
2004-03-26 |
2005-10-20 |
Univ Stuttgart |
Rekombinante Polypeptide der Mitglieder der TNF Ligandenfamilie und deren Verwendung
|
|
US20060034850A1
(en)
|
2004-05-27 |
2006-02-16 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
|
US7670595B2
(en)
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
|
CN109485727A
(zh)
|
2005-05-09 |
2019-03-19 |
小野药品工业株式会社 |
程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法
|
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
KR20080082628A
(ko)
|
2005-11-10 |
2008-09-11 |
리셉터 바이오로직스 인크 |
수용체 및 리간드 이소형태의 제조 방법
|
|
US7943133B2
(en)
|
2006-02-02 |
2011-05-17 |
Boston Biocom Llc |
Mesothelin antibody protein fusions and methods of use
|
|
EP1996937A4
(en)
|
2006-03-06 |
2009-04-08 |
Amunix Inc |
GENETIC PACKS AND USES THEREOF
|
|
US8518697B2
(en)
|
2006-04-04 |
2013-08-27 |
Washington University |
Single chain trimers and uses therefor
|
|
ES2549128T3
(es)
|
2006-05-19 |
2015-10-23 |
Technion Research And Development Foundation Ltd. |
Proteínas de fusión, usos de las mismas y procesos para producir las mismas
|
|
EP1889851A1
(en)
|
2006-08-18 |
2008-02-20 |
Charite Universitätsmedizin-Berlin |
PAX2 and PAX8 as targets for immunologic and molecular tumour treatment strategies
|
|
US8992937B2
(en)
|
2006-08-28 |
2015-03-31 |
Washington University |
Disulfide trap MHC class I molecules and uses therefor
|
|
CN101573448B
(zh)
|
2006-12-28 |
2012-07-11 |
株式会社癌免疫研究所 |
Hla-a*1101限制的wt1肽及含有其的药物组合物
|
|
EP2129389B1
(en)
|
2007-02-15 |
2014-10-08 |
MannKind Corporation |
A method for enhancing t cell response
|
|
WO2008113970A2
(en)
|
2007-03-16 |
2008-09-25 |
Ucl Business Plc |
Peptides
|
|
EP2361930A3
(en)
|
2007-03-26 |
2011-10-26 |
Dako Denmark A/S |
Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
|
|
EP2615172A1
(en)
|
2007-04-27 |
2013-07-17 |
Pfenex Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
|
BRPI0815416A2
(pt)
|
2007-08-15 |
2014-10-21 |
Amunix Inc |
Composições e métodos para modificar propriedades de polipeptídeos biologicamente ativos
|
|
US8926961B2
(en)
|
2007-10-03 |
2015-01-06 |
Board Of Trustees Of The University Of Arkansas |
HPV E6 protein T cell epitopes and uses thereof
|
|
CN101418309B
(zh)
|
2007-10-23 |
2011-05-04 |
中国农业科学院上海兽医研究所 |
柔嫩艾美耳球虫蛋白质二硫键异构酶基因的克隆、表达及应用
|
|
DE102008023820A1
(de)
|
2008-05-08 |
2009-11-12 |
Aicuris Gmbh & Co. Kg |
Mittel zur Behandlung und/oder Prophylaxe einer Autoimmunerkrankung und zur Bildung von Regulatorischen T-Zellen
|
|
TW201008574A
(en)
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
|
US20110318380A1
(en)
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
|
EP2184070A1
(en)
|
2008-11-07 |
2010-05-12 |
Hla-G Technologies |
HLA-G proteins and pharmaceutical uses thereof
|
|
WO2010077634A1
(en)
|
2008-12-09 |
2010-07-08 |
Genentech, Inc. |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
MX2011007647A
(es)
|
2009-01-21 |
2011-09-01 |
Amgen Inc |
Composiciones y metodos para el tratamiento de enfermedades inflamatorias y autoinmunes.
|
|
WO2010091122A1
(en)
|
2009-02-03 |
2010-08-12 |
Amunix, Inc. |
Extended recombinant polypeptides and compositions comprising same
|
|
US20120178703A1
(en)
|
2009-06-25 |
2012-07-12 |
Commisariat A L'energie Atomique Et Aux Energies Alternatives |
Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof
|
|
US20130017199A1
(en)
|
2009-11-24 |
2013-01-17 |
AMPLIMMUNE ,Inc. a corporation |
Simultaneous inhibition of pd-l1/pd-l2
|
|
NZ599405A
(en)
|
2009-11-24 |
2014-09-26 |
Medimmune Ltd |
Targeted binding agents against b7-h1
|
|
US9695410B2
(en)
|
2010-07-15 |
2017-07-04 |
Technion Research & Development Foundation Limited |
Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides
|
|
CN105017429B
(zh)
|
2010-09-21 |
2021-04-06 |
阿尔托生物科学有限公司 |
多聚体il-15可溶性融合分子与其制造与使用方法
|
|
WO2012088446A1
(en)
|
2010-12-22 |
2012-06-28 |
Board Of Trustees Of The Leland Stanford Junior University |
Superagonists and antagonists of interleukin-2
|
|
LT3075745T
(lt)
|
2011-02-10 |
2018-11-26 |
Roche Glycart Ag |
Mutavę interleukino-2 polipeptidai
|
|
WO2012127464A2
(en)
|
2011-03-23 |
2012-09-27 |
Gavish-Galilee Bio Applications Ltd |
Constitutively activated t cells for use in adoptive cell therapy
|
|
EA201892619A1
(ru)
|
2011-04-29 |
2019-04-30 |
Роше Гликарт Аг |
Иммуноконъюгаты, содержащие мутантные полипептиды интерлейкина-2
|
|
ES2667864T3
(es)
|
2011-06-22 |
2018-05-14 |
F. Hoffmann-La Roche Ag |
Eliminación de células diana mediante linfocitos T citotóxicos específicos de virus en circulación usando complejos que comprenden MHC de clase I
|
|
EP2726101B1
(en)
|
2011-06-30 |
2018-08-08 |
Genzyme Corporation |
Inhibitors of t-cell activation
|
|
WO2013030620A2
(de)
|
2011-08-30 |
2013-03-07 |
Jacobs University Bremen Ggmbh |
Gen codiert für ein mhc-klasse-i-molekül, plasmid, expressionssystem protein, multimer, reagenz und kit zum analysieren einer t-zellen-frequenz
|
|
US8956619B2
(en)
|
2011-10-25 |
2015-02-17 |
University Of Maryland, Baltimore County |
Soluble CD80 as a therapeutic to reverse immune supression in cancer patients
|
|
EP2785375B1
(en)
|
2011-11-28 |
2020-07-22 |
Merck Patent GmbH |
Anti-pd-l1 antibodies and uses thereof
|
|
AU2013207669C1
(en)
|
2012-01-13 |
2018-05-31 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
WO2013116656A1
(en)
|
2012-02-03 |
2013-08-08 |
Emory University |
Immunostimulatory compositions, particles, and uses related thereto
|
|
US20140044675A1
(en)
|
2012-08-10 |
2014-02-13 |
Roche Glycart Ag |
Interleukin-2 fusion proteins and uses thereof
|
|
BR112015011111A2
(pt)
|
2012-11-30 |
2017-11-14 |
Roche Glycart Ag |
proteína multifuncional e formulação farmacêutica
|
|
CN105121715B
(zh)
|
2012-12-11 |
2018-10-26 |
艾伯特叶史瓦大学爱因斯坦医学院 |
高通量受体:配体鉴定方法
|
|
RU2015129640A
(ru)
|
2012-12-21 |
2017-01-26 |
Ф.Хоффманн-Ля Рош Аг |
Связанные дисульфидом мультивалентные многофункциональные белки, содержащие молекулы гкгс класса 1
|
|
PT2945647T
(pt)
|
2013-01-15 |
2020-11-26 |
Memorial Sloan Kettering Cancer Center |
Péptidos imunogénicos wt-1 e métodos de uso dos mesmos
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
EP2948475A2
(en)
|
2013-01-23 |
2015-12-02 |
AbbVie Inc. |
Methods and compositions for modulating an immune response
|
|
EP3587448B1
(en)
|
2013-03-15 |
2021-05-19 |
Xencor, Inc. |
Heterodimeric proteins
|
|
HK1220376A1
(zh)
|
2013-03-15 |
2017-05-05 |
Angelica Therapeutics, Inc. |
修饰的毒素
|
|
WO2014157692A1
(ja)
|
2013-03-29 |
2014-10-02 |
大日本住友製薬株式会社 |
Ｗｔ１抗原ペプチドコンジュゲートワクチン
|
|
CN111781359A
(zh)
|
2013-05-13 |
2020-10-16 |
株式会社癌免疫研究所 |
用于预测免疫疗法的临床效果的方法
|
|
GB201311475D0
(en)
|
2013-06-27 |
2013-08-14 |
Alligator Bioscience Ab |
Polypeptides
|
|
BR112016001114B1
(pt)
|
2013-07-19 |
2023-02-14 |
Vib Vzw |
Composição compreendendo uma proteína de fusão e uso da referida composição
|
|
CN119775416A
(zh)
|
2013-12-24 |
2025-04-08 |
杨森制药公司 |
抗vista抗体及片段
|
|
SG11201605632SA
(en)
|
2014-01-21 |
2016-08-30 |
Einstein Coll Med |
Cellular platform for rapid and comprehensive t-cell immunomonitoring
|
|
US20160152725A1
(en)
|
2014-02-25 |
2016-06-02 |
Memorial Sloan-Kettering Cancer Center |
Antigen-binding proteins specific for hla-a2-restricted wilms tumor 1 peptide
|
|
EP3112378B1
(en)
|
2014-02-26 |
2020-06-24 |
Tella, Inc. |
Wt1 antigenic polypeptide, and anti-tumor agent containing said polypeptide
|
|
JP6592505B2
(ja)
|
2014-04-24 |
2019-10-16 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
インターロイキン−２のスーパーアンタゴニスト、パーシャルアゴニスト及びアンタゴニスト
|
|
SG10202006338UA
(en)
*
|
2014-06-18 |
2020-08-28 |
Albert Einstein College Medicine Inc |
Syntac polypeptides and uses thereof
|
|
CN106604742B
(zh)
|
2014-07-03 |
2019-01-11 |
百济神州有限公司 |
抗pd-l1抗体及其作为治疗剂及诊断剂的用途
|
|
DK3172227T3
(da)
|
2014-07-21 |
2019-12-02 |
Delinia Inc |
Molekyler der selektivt aktiverer regulatoriske t-celler til behandlingen af autoimmune sygdomme
|
|
AU2015301753B2
(en)
*
|
2014-08-12 |
2021-04-08 |
Massachusetts Institute Of Technology |
Synergistic tumor treatment with IL-2 and integrin-binding-Fc-fusion protein
|
|
US11111284B2
(en)
|
2014-08-21 |
2021-09-07 |
The General Hospital Corporation |
Tumor necrosis factor superfamily and TNF-like ligand muteins and methods of preparing
|
|
AU2015308527C1
(en)
*
|
2014-08-29 |
2021-07-15 |
F. Hoffmann-La Roche Ag |
Combination therapy of tumor-targeted IL-2 variant immunocytokines and antibodies against human PD-L1
|
|
CN107531805A
(zh)
|
2015-03-05 |
2018-01-02 |
弗雷德哈钦森癌症研究中心 |
免疫调节融合蛋白及其用途
|
|
EP3286222A4
(en)
|
2015-03-23 |
2018-08-08 |
The Johns Hopkins University |
Hla-restricted epitopes encoded by somatically mutated genes
|
|
EP3283508B1
(en)
|
2015-04-17 |
2021-03-17 |
Alpine Immune Sciences, Inc. |
Immunomodulatory proteins with tunable affinities
|
|
US12011480B2
(en)
|
2015-05-06 |
2024-06-18 |
Uti Limited Partnership |
Nanoparticle compositions for sustained therapy
|
|
EP3322732A2
(en)
|
2015-07-13 |
2018-05-23 |
Cytomx Therapeutics Inc. |
Anti-pd-1 antibodies, activatable anti-pd-1 antibodies, and methods of use thereof
|
|
US11046745B2
(en)
|
2015-07-14 |
2021-06-29 |
BioNTech SE |
Peptide mimotopes of the CD3 T-cell co-receptor epsilon chain and uses thereof
|
|
CN106397592A
(zh)
|
2015-07-31 |
2017-02-15 |
苏州康宁杰瑞生物科技有限公司 |
针对程序性死亡配体(pd-l1)的单域抗体及其衍生蛋白
|
|
US20180221503A1
(en)
|
2015-07-31 |
2018-08-09 |
Tarveda Therapeutics, Inc. |
Compositions and methods for immuno-oncology therapies
|
|
CN106565836B
(zh)
|
2015-10-10 |
2020-08-18 |
中国科学院广州生物医药与健康研究院 |
高亲和力的可溶性pdl-1分子
|
|
CN116327902A
(zh)
|
2015-11-20 |
2023-06-27 |
纪念斯隆凯特林癌症中心 |
用于治疗癌症的方法和组合物
|
|
US20190365656A1
(en)
|
2016-01-04 |
2019-12-05 |
Cour Pharmaceuticals Development Company, Inc. |
Particles encapsulating fusion proteins containing linked epitopes
|
|
CA3012037A1
(en)
|
2016-01-27 |
2017-08-03 |
Csl Behring Recombinant Facility Ag |
Recombinant igg fc multimers
|
|
EP3423108A4
(en)
|
2016-03-02 |
2019-10-02 |
Cue Biopharma, Inc. |
T CELL MODULATING MULTIPLE POLYPEPTIDES AND METHOD OF USE THEREOF
|
|
CA3014466A1
(en)
|
2016-03-03 |
2017-09-08 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
KR20240115933A
(ko)
|
2016-05-04 |
2024-07-26 |
암젠 인크 |
T-조절 세포의 증식을 위한 인터류킨-2 뮤테인
|
|
CN109475628A
(zh)
*
|
2016-05-18 |
2019-03-15 |
库尔生物制药有限公司 |
T细胞调节性多聚体多肽及其使用方法
|
|
CA3022331A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Albert Einstein College Of Medicine, Inc. |
Variant pd-l1 polypeptides, t-cell modulatory multimeric polypeptides, and methods of use thereof
|
|
EP3538559B1
(en)
|
2016-11-09 |
2025-04-09 |
UTI Limited Partnership |
Recombinant pmhc class ii molecules
|
|
AU2017379900B2
(en)
|
2016-12-22 |
2024-12-05 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
WO2018129474A1
(en)
|
2017-01-09 |
2018-07-12 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
EP3592381A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Cancer vaccine
|
|
EP3596118B1
(en)
|
2017-03-15 |
2024-08-21 |
Cue Biopharma, Inc. |
Combination of multimeric fusion polypeptides and immune checkpoint inhibitor for treating hpv-associated cancer
|
|
EP3595706A1
(en)
|
2017-03-17 |
2020-01-22 |
Fred Hutchinson Cancer Research Center |
Immunomodulatory fusion proteins and uses thereof
|
|
EP3446702A1
(en)
|
2017-08-23 |
2019-02-27 |
Medizinische Hochschule Hannover |
Synthetic vaccine
|
|
JP2021500855A
(ja)
|
2017-09-07 |
2021-01-14 |
キュー バイオファーマ， インコーポレイテッド |
抗原提示ポリペプチドおよびその使用方法
|
|
WO2019051126A1
(en)
|
2017-09-07 |
2019-03-14 |
Cue Biopharma, Inc. |
ANTIGEN PRESENTING POLYPEPTIDES COMPRISING CHEMICAL CONJUGATION SITES AND METHODS OF USE THEREOF
|
|
WO2019051127A1
(en)
|
2017-09-07 |
2019-03-14 |
Cue Biopharma, Inc. |
MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF
|
|
IL297361B2
(en)
|
2017-09-07 |
2024-07-01 |
Cue Biopharma Inc |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
WO2019070541A1
(en)
|
2017-10-03 |
2019-04-11 |
Juno Therapeutics, Inc. |
HPV-SPECIFIC BINDING MOLECULES
|
|
WO2019139896A1
(en)
|
2018-01-09 |
2019-07-18 |
Cue Biopharma, Inc. |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
EP3755711A4
(en)
|
2018-02-20 |
2021-11-24 |
Technion Research & Development Foundation Limited |
IMMUNOTHERAPEUTIC COMPOSITION FOR THE TREATMENT OF CANCER
|
|
WO2020132135A1
(en)
|
2018-12-19 |
2020-06-25 |
Cue Biopharma, Inc. |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
TWI856047B
(zh)
|
2018-12-19 |
2024-09-21 |
美商信號生物製藥公司 |
多聚體ｔ細胞調節多肽及其使用方法
|
|
WO2020132136A1
(en)
|
2018-12-19 |
2020-06-25 |
Cue Biopharma, Inc. |
Multimeric t-cell modulatory polypeptides and methods of use thereof
|
|
BR112021011838A2
(pt)
|
2018-12-19 |
2021-08-31 |
Cue Biopharma, Inc. |
Peptídeos multiméricos moduladores de células t e métodos de uso destes
|
|
EP3935079A4
(en)
|
2019-03-06 |
2023-03-22 |
Cue Biopharma, Inc. |
T LYMPHOCYTE MODULATOR ANTIGEN PRESENTING POLYPEPTIDES AND METHODS OF USE THEREOF
|
|
EP3935080A4
(en)
|
2019-03-06 |
2023-04-05 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
CN118852456A
(zh)
|
2019-05-29 |
2024-10-29 |
Cue生物制药股份有限公司 |
多聚体t细胞调节多肽及其使用方法
|
|
AU2020287373A1
(en)
|
2019-06-05 |
2022-01-06 |
Asher Biotherapeutics, Inc. |
Fusions of mutant interleukin-2 polypeptides with antigen binding molecules for modulating immune cell function
|
|
EP3986448A4
(en)
|
2019-06-19 |
2023-07-12 |
Cue Biopharma, Inc. |
MULTIMERIC T-CELL-MODULATING POLYPEPTIDES AND METHODS OF USE THEREOF
|
|
EP4030897A4
(en)
|
2019-09-20 |
2023-10-18 |
Cue Biopharma, Inc. |
T-cell modulatory polypeptides and methods of use thereof
|
|
JP2023500574A
(ja)
|
2019-10-23 |
2023-01-10 |
キュー バイオファーマ， インコーポレイテッド |
Ｔ細胞調節性キメラ分子及びその使用方法
|
|
AU2020369573A1
(en)
|
2019-10-23 |
2022-03-24 |
Cue Biopharma, Inc. |
Modified cytotoxic T cells and methods of use thereof
|
|
WO2021113297A1
(en)
|
2019-12-02 |
2021-06-10 |
Regeneron Pharmaceuticals, Inc. |
Peptide-mhc ii protein constructs and uses thereof
|
|
US20210188934A1
(en)
|
2019-12-20 |
2021-06-24 |
Regeneron Pharmaceuticals, Inc. |
Novel il2 agonists and methods of use thereof
|
|
KR20220147107A
(ko)
|
2020-02-28 |
2022-11-02 |
도쿠리츠다이가쿠호징 가나자와다이가쿠 |
면역 제어법, 면역 제어용 핵산 조성물 및 그의 용도
|
|
GB202005617D0
(en)
|
2020-04-17 |
2020-06-03 |
Adaptimmune Ltd |
Improved t cell manufacturing process
|
|
EP4149534A4
(en)
|
2020-05-12 |
2024-09-04 |
Cue Biopharma, Inc. |
MULTIMERIC POLYPEPTIDES MODULATING T CELLS AND METHODS OF USE THEREOF
|
|
CN113823723A
(zh)
|
2020-06-18 |
2021-12-21 |
光宝光电(常州)有限公司 |
发光二极管封装结构
|
|
WO2022015880A2
(en)
|
2020-07-14 |
2022-01-20 |
Cue Biopharma, Inc. |
T-cell modulatory polypeptides with conjugation sites and methods of use thereof
|
|
IL302276A
(en)
|
2020-10-23 |
2023-06-01 |
Asher Biotherapeutics Inc |
Fusions with cd8 antigen binding molecules for modulating immune cell function
|
|
WO2022125711A1
(en)
|
2020-12-09 |
2022-06-16 |
Asher Biotherapeutics, Inc. |
Targeted cytokine construct for engineered cell therapy
|
|
WO2022125694A1
(en)
|
2020-12-09 |
2022-06-16 |
Asher Biotherapeutics, Inc. |
Fusions of interleukin polypeptides with bispecific antigen binding molecules for modulating immune cell function
|